Stay connected with HLK
Keep up-to-date with the latest IP insights and updates as well as upcoming webinars and seminars via HLK’s social media.
Our Life Sciences and Healthcare team have delved into the recent valuable changes and updates relevant to patenting life sciences, healthcare and medical innovations in Europe.
Our speakers explored how the EPO’s Board of Appeal has significantly expanded the range of products that can be protected when used in medical methods and shared their insights on the impact of this development for healthcare companies’ IP strategy in Europe, and looked at how recent global developments affect strategy on patenting antibodies in Europe.
Our experts in life sciences and healthcare covered the following topics:
- What is a “substance or composition”? Filling the gap for second medical use claims
- Changes in the EPO Guidelines from 1 March 2024
- Patenting antibodies in Europe in light of recent global developments
Speakers
Isobel Finnie – Partner, UK and European Patent Attorney
Joanna Deas – Partner, UK and European Patent Attorney
Michael Ford – Senior Associate, UK and European Patent Attorney
